SCHEMBL27434682

SCHEMBL27434682

Oc1ccc2oc3cc4c(cc3c2c1)oc1ccccc14

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.68
MAPT P10636 4/20 0.59
KDM4E B2RXH2 4/20 0.59
ALDH1A1 P00352 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
LMNA P02545 1/20 0.59
ALOX15 P16050 1/20 0.59
HTT P42858 1/20 0.59
HSD17B10 Q99714 1/20 0.59
MEN1 O00255 3/20 0.55
HPGD P15428 3/20 0.55
KMT2A Q03164 3/20 0.55
AHR P35869 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
NPSR1 Q6W5P4 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
ALOX5 P09917 1/20 0.51
DYRK1A Q13627 2/20 0.50
CALM1 P0DP23 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL905380 0.96 MAOA (0.72) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL31153220 0.88 MAOA (0.79) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL2757860 0.88 MAOA (0.79) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL11831965 0.85 KDM4E (0.82) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL571563 0.85 AHR (0.71) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL16919496 0.85 AHR (0.71) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL5308204 0.85 MAPT (0.64) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL23615509 0.84 MAOA (0.50) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
Xanthone SCHEMBL29025600 0.81 MAOA (1.00) MAOAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL1675981 0.81 MAOA (1.00) MAOAMAPTKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217902-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217902-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, AOC1 MAOA 616/4885MAPT 754/4885KDM4E 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.